Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 | 192808048 | intron variant | C/A | snv | 1.2E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1 | 192808048 | intron variant | C/A | snv | 1.2E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2013 | 2018 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Nervous System Diseases | 0.030 | 1.000 | 3 | 2007 | 2010 | ||||||||
|
1 | 192810186 | missense variant | G/A | snv | 1.2E-04 | 7.0E-05 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2005 | 2008 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2009 | 2018 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
0.882 | 0.160 | 1 | 192808434 | intron variant | A/G | snv | 0.35 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 1 | 192808434 | intron variant | A/G | snv | 0.35 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 1 | 192808434 | intron variant | A/G | snv | 0.35 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 1 | 192808434 | intron variant | A/G | snv | 0.35 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.080 | 1 | 192808677 | intron variant | G/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1 | 192810962 | intron variant | TC/CT | mnv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.752 | 0.120 | 1 | 192812042 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 |